California Yaz Lawyers and Yasmin Drug Fraud Attorneys, Pharmaceutical Product Liability Lawyers for Those Who Have Suffered Heart Attack, Stroke, Thromboembolism, Pulmonary Embolism, Hepatic Neoplasia, Hypertension, Cardiac Arrhythmia, Blood Clots, Deep Vein Thrombosis, DVT, Gallbladder Disease and Other Side Effects. Our Yaz Drug and Fraud Lawyers Serve All of California from San Diego to Sacramento, Los Angeles, San Francisco, the Bay Area, Orange County, San Jose and Santa Clara County.

Our California Yaz attorneys are experienced pharmaceutical product liability lawyers and drug fraud attorneys. Our Yaz lawyers will consider cases involving heart attack and stroke, other venous and arterial thrombotic and thromboembolic events, deep vein thrombosis, DVT, thromboembolism, pulmonary embolism and blood clots and well as hypertension, cardiac arrhythmia, gallbladder disease and other side effects resulting from the use of Yaz or Yasmin. We will consider cases arising throughout the state of California, from Los Angeles to San Francisco and the Bay Area, in Orange County and San Jose, Santa Clara County, from San Diego to Sacramento.

Free California Yaz Lawyer Consultation: If you suffered a heart attack, stroke, cardiac arrhythmia, blood clots, deep vein thrombosis, pulmonary embolism or gallbladder disease while taking Yaz or Yasmin, our California Yaz lawyers welcome you to contact us for a free consultation. You may submit the "Contact" form and one of our Yaz attorneys will call you to discuss your case. Our Yaz lawyer case consultations are entirely free of charge and without obligation.

Our California Yaz Drug Fraud Lawyers Discuss The Advantages of Bringing Fraud and Misrepresentation Causes of Action Against the Bayer Entities for Misrepresenting the Benefits and Minimizing the Risks Associated with Yaz and Yasmin.

The Yaz/Yasmin Lawsuits are relatively unique as pharmaceutical product liability litigation because of the evidence of misrepresentation, fraud and over-promotion of the drugs, both misrepresenting the potential benefits and minimizing the risks. Our Yaz lawyers, including Mr. Henke, are highly experienced in pharmaceutical product liability cases and specifically qualified in drug fraud litigation. Indeed, our drug fraud litigation has been chronicled from the front page of the New York Times to the front page of the Los Angeles Times from the Washington Post to the San Francisco Chronicle and Examiner, in the legitimate national and international television news, from Tom Brokaw's NBC Nightly News to CNN, and Mr. Henke has testified before Congress specifically on the subject of drug fraud at the invitation of the Chairman of the Judiciary Committee of the United States House of Representatives.

The evidence of the Bayer entities over-promotion and misrepresentation of both the benefits and risks of Yaz have yielded the concurrence of the FDA, in letters to the manufacturer. In 2003 the FDA wrote to Bertex Laboratories, then the manufacturer of Yasmin, a company subsequently purchased by the Bayer entities, stating: "The TV ad misleadingly overstates the efficacy and safety of Yasmin by suggesting that Yasmin is unique and therefore clinically superior to other birth control pills because it contains the chemically different progestin drospirinon." Despite the FDA correspondence, Bertex and then Bayer continued to mislead the public in their advertising, both misrepresenting the drug as superior to other birth control pharmaceuticals and minimizing the risks.

In 2008 the FDA wrote to Bayer, again warning of the misleading character of its television advertisements for Yaz and Yasmin to obscure the risks of the drug. According to the FDA "The overall effect of the distracting visuals, graphics, concurrent supers and background music is to undermine the communication of the important risk information, minimizing these risks and misleadingly suggesting that Yaz is safer than has been demonstrated by substantial evidence or substantial clinical experience." And the risks that the FDA considered were minimized by Bayer in its advertising, included venous and arterial thrombotic and thromboembolic events, such as myocardial infarction (heart attack), thromboembolism and stroke, hepatic neoplasia, gallbladder disease and hypertension.

Our Yaz drug fraud lawyers consider that there are substantial advantages to including fraud and misrepresentation "causes of action" to the usual strict product liability and negligence claims commonly brought in drug product liability litigation. One advantage is that there will be the potential to obtain "punitive damages," in addition to the usual compensatory damages, to punish the drug company for its misrepresentations and to set an example so that other drug companies will not use the same tactic of misrepresentation again.

As the result of the Bayer entities misrepresentation of the benefits and risks of Yas and Yasmin in its television commercials it quickly obtained an advantage over the other manufacturers of birth control pills. Our Yaz drug fraud lawyers consider that the success of Yaz and Yasmin indeed can be directly attributable to its misrepresentations with regard to the drugs purported benefits over other birth control pharmaceuticals. The Bayer entities have made their huge profits in substantial part because of their advertising misrepresentations, and as our Yaz drug fraud lawyers analyze it, punitive damages would be justified to strip Bayer of its ill-gained profit and to set the example for other drug companies that they too must refrain from misrepresentation as the means to gain the competitive advantage.

Our Yaz Drug Side Effect Attorneys and Drug Fraud Lawyers Explain Some of the Advantages of Multi-District Litigation and Class Action.

Many of the factors that would weigh upon the decision to file or join a Yaz class action, or file a case in federal court to be joined with the cases now pending in Multi-District Litigation have yet to satisfy our Yaz lawyers. Many cases have been filed in the federal court, and in October 2009 the Judicial Panel on Multi-District Litigation made a ruling joining the cases together for pre-trial purposes, such as discovery. In that sense, MDL can be very useful, and can result in substantial savings for individual litigants as the costs associated with obtaining the discovery, as an example, the depositions of the Bayer management and employees.

It is also possible that a Yaz class action will be filed, although, our Yaz lawyers again would have to consider how the class action is framed, as we have been at the forefront in objecting to certain types of class action specifically in pharmaceutical product liability litigation. Again, there can be substantial advantages to certain class actions, including shared discovery costs, and often the class litigation will lead to fair settlements, however, there can also be advantages to trying cases individually, and our Yaz lawyers have been at the forefront in looking at pharmaceutical class actions critically and advising our clients about the benefits and potential detriments of joining class actions.

Indeed, our Yaz lawyer, Ray Henke, obtained the landmark federal appellate decision severely restricting the availability of mandatory class action to permit clients to chose whether to "opt in" or "opt out" of pharmaceutical class actions. One thousand federal cases involving children who had suffered serious birth defects resulting from a drug promoted for use in pregnancy were first joined together in Multi-District Litigation and assigned to a federal District Court Judge for the Southern District of Ohio. The federal Judge then certified a "mandatory class action" by which he purported to join all cases nationwide, including those filed in the state courts. The Plaintiffs Lead Counsel Committee and the lawyers for the pharmaceutical company then settled the case for $120,000,000, and the federal Judge approved the settlement. Mr. Henke's firm had 40 cases involving children who had classic limb defects whose mothers had taken the teratogenic drug during the critical period of days when the fetuses limb buds were forming. Many other lawyers represented thousands of children who were similarly very tragically crippled. We considered that the settlement, which would result in only a few thousand dollars in compensation to the individual plaintiffs was woefully inadequate. Mr. Henke filed a petition for writ of mandamus, a type of appeal, in the United States Court of Appeals for the Sixth Circuit. He argued that the certification of the "mandatory class action" violated his clients rights to the lawyer of their choice and to control over their individual litigation. The federal Court of Appeals agreed, ordering the District Court to decertify the mandatory class action and void the settlement. The federal Court of Appeals also published a landmark decision on Henke's petition for writ of mandamus, adopting the line of reasoning argued in Henke's brief, severely restricting the availability of "mandatory class actions" so that in the Yaz litigation, as an example, only a "voluntary class action" would be sustainable, providing the client with the opportunity to "opt-in" or "opt-out."

The determination whether to file a case in state court or federal court to join in the MDL proceedings or to file or join a class action are issues that we consider important to discuss with the client. Some lawyers are incapable of trying complex pharmaceutical product liability cases and therefore only file their cases in class actions. Our California Yaz lawyers are capable of trying these complex cases, and will consider the advantages and disadvantages with our clients.

In terms of the MDL, our California Yaz lawyers will, for the moment, watch, and consider whether there will be an effort to standardize the "complaints" and whether any standard complaint that is adopted will include fraud and misrepresentation causes of action and claims for punitive damages, among other considerations of benefits and detriments of pursuing our individual cases in federal court as opposed to California state court. If a Yaz class action is filed, we will consider with our clients the benefits and potential detriments of opting-in to the class.

Our California Yaz Lawyers Welcome You To Contact Us if You Have Suffered a Heart Attack or Stroke, Deep Vein Thrombosis, DVT, Thromboembolism, pulmonary embolism, Hypertension, Cardiac Arrhythmia, Gallbladder Disease and Other Side Effects Resulting from Yaz or Yasmin. Our California Yaz Drug Product Liability Lawyers and Drug Fraud Attorneys Serve our Clients from Los Angeles to San Francisco and the Bay Area, in Orange County and San Jose, from San Diego to Sacramento. Our Yaz Lawyers Welcome the Opportunity to Speak with You.

If you have suffered a heart attack or stroke or other venous or arterial thrombotic or thromboembolic event, deep vein thrombosis, DVT, thromboembolism, pulmonary embolism, blood clots, hypertension, cardiac arrhythmia, gallbladder disease or another side effect of Yaz or Yasmin, our pharmaceutical product liability lawyers and Yaz drug fraud attorneys welcome you to contact us for a free consultation.

You are invited to submit the "Contact" form and one of our Yaz attorneys will promptly call you to discuss your potential case. We welcome the opportunity to speak with you.